Kopfbereich

additional navigation

Logo

You are here:

Current studies


Indication: patients with septic shock and persistent tachycardia
Study name: LANDI-SEP; EudraCT Nr 2017-002138-22

  • Phase IV, multicenter, prospective, randomized, open-label
  • controlled study on Landiolol in patients with septic shock resident in an Intensive Care Unit 
  • Link to details on Clinicaltrialsregister.eu

Indication: supraventricular tachycardia in pediatric patients
Study name: LANDI-PED; EudraCT Nr 2015-001129-17

  • A multicenter, open-label study to investigate the effectiveness and safety of AOP Landiolol in controlling supraventricular tachycardia in pediatric patients
  • Link to details on Clinicaltrialsregister.eu

Indication: Polycythemia Vera
Study name: CONTINUATION-PV; EudraCT Nr 2014-001357-17

  • An open-label, multicenter, phase IIIb study assessing the long-term efficacy and safety of AOP2014 and standard first line treatment (BAT) in patients with Polycythemia Vera who previously participated in the PROUD-PV study
  • Link to details on Clinicaltrials.gov

AOP Orphan Contact

AOP Orphan Austria

AOP Orphan worldwide

Products & Area of treatment